Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALOGLIPTIN Cause Blood creatinine increased? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Blood creatinine increased have been filed in association with ALOGLIPTIN (Alogliptin and Pioglitazone). This represents 1.1% of all adverse event reports for ALOGLIPTIN.

15
Reports of Blood creatinine increased with ALOGLIPTIN
1.1%
of all ALOGLIPTIN reports
5
Deaths
13
Hospitalizations

How Dangerous Is Blood creatinine increased From ALOGLIPTIN?

Of the 15 reports, 5 (33.3%) resulted in death, 13 (86.7%) required hospitalization, and 6 (40.0%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does ALOGLIPTIN Cause?

Pemphigoid (98) Pancreatitis (66) Diarrhoea (60) Nausea (60) Rash (55) Hypoglycaemia (46) Vomiting (44) Pancreatitis acute (43) Drug ineffective (42) Pruritus (42)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which ALOGLIPTIN Alternatives Have Lower Blood creatinine increased Risk?

ALOGLIPTIN vs ALOGLIPTIN\METFORMIN ALOGLIPTIN vs ALOGLIPTIN\PIOGLITAZONE ALOGLIPTIN vs ALOSETRON ALOGLIPTIN vs ALPELISIB ALOGLIPTIN vs ALPHA.-LIPOIC ACID

Related Pages

ALOGLIPTIN Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased ALOGLIPTIN Demographics